Pro Health Tips
Thursday, 3 December 2020
Discontinuing Tyrosine Kinase Inhibitors can Improve Outcomes in Leukemia Patients
Discontinuing Tyrosine Kinase inhibitor (TKI) in patients suffering from chronic myeloid leukemia (CML) has shown better patient reported outcomes.
from Medindia Health News https://ift.tt/3ok5Tru
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
Discontinuing Tyrosine Kinase inhibitor (TKI) in patients suffering from chronic myeloid leukemia (CML) has shown better patient reported outcomes.
No comments:
Post a Comment